Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Epidemiology and Community Health 2000;54:444-450; doi:10.1136/jech.54.6.444
Copyright © 2000 by the BMJ Publishing Group Ltd.
J Epidemiol Community Health 2000;54:444-450 ( June )

Research report

Seroconversion and seroreversion in IgG antibodies to Helicobacter pylori: a serology based prospective cohort study Steffen Rosenstocka, Torben Jørgensena, Leif Andersenb, Olaf Bonneviec

a Copenhagen County Centre of Preventive Medicine, Glostrup University Hospital, Glostrup, Denmark, b Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark, c Department of Medicine I, Bispebjerg Hospital, Copenhagen, Denmark

Correspondence to: Dr Rosenstock, Department of Surgery A, Centralsygehuset Hillerød, Helsevej 2, 3400 Hillerød, Denmark (e-mail: rosenstock.s{at}dadlnet.dk)

Accepted for publication 29 September 1999

STUDY OBJECTIVES---To assess the incidence of seroconversion and seroreversion in IgG antibodies to Helicobacter pylori within a 11 year observation period using these events as markers for acquisition and loss of the infection, respectively.
DESIGN---Population based prospective cohort study
SETTING---Northern part of Copenhagen County, Denmark
PARTICIPANTS AND METHODS---A random sample of 2527 Danish adults were examined and blood obtained in 1983 and in 1994. Matching pairs of sera were analysed for the presence of IgG and IgM antibodies to H pylori with an in house enzyme linked immunosorbent assay. Participants who were seronegative at study entry and seropositive at follow up and had a fourfold increase in baseline IgG antibody levels were categorised as seroconverters and regarded as having acquired H pylori infection. Participants who were seropositive at study entry and had at least a fourfold decrease in baseline IgG antibody levels at follow up were assumed to have lost the infection (seroreverters).
RESULTS---The seroprevalence of H pylori infection was 24.7 (95% confidence intervals (95% CI) 23.0, 26.4) % in 1983 and 24.5 (95% CI 22.8, 26.2) % in 1994. A total of 14 participants seroconverted within the observation period (cumulative 11 year incidence proportion: 1.0 (95% CI 0.5, 1.5) %). Having increased IgM antibody levels at study entry significantly increased the likelihood of IgG seroconversion (relative risk 6.4 (95% CI 2.1, 19.6). Seroreversion was seen in 48 participants (cumulative 11 year incidence proportion: 7.7 (95% CI 5.6, 9.8) %).
CONCLUSIONS---Changes in H pylori infection status with time are rare in Danish adults. Few adults become infected with H pylori in Denmark.


Keywords: Helicobacter pylori; seroconversion; sero-reversion


© 2000 by Journal of Epidemiology and Community Health

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Tschopp, A, Joller, H, Jeggli, S, Widmeier, S, Steffen, R, Hilfiker, S, Hotz, P (2009). Hepatitis E, Helicobacter pylori and peptic ulcers in workers exposed to sewage: a prospective cohort study. Occup. Environ. Med. 66: 45-50 [Abstract] [Full Text]  
  • Perry, S., Parsonnet, J. (2005). Commentary: H. pylori infection in early life and the problem of imperfect tests. Int J Epidemiol 34: 1356-1358 [Full Text]  
  • Windle, H J, Ang, Y S, Morales, V A, McManus, R, Kelleher, D (2005). Human peripheral and gastric lymphocyte responses to Helicobacter pylori NapA and AphC differ in infected and uninfected individuals. Gut 54: 25-32 [Abstract] [Full Text]  
  • Risch, H. A. (2003). Etiology of Pancreatic Cancer, With a Hypothesis Concerning the Role of N-Nitroso Compounds and Excess Gastric Acidity. JNCI J Natl Cancer Inst 95: 948-960 [Abstract] [Full Text]  
  • Rosenstock, S, Jorgensen, T, Bonnevie, O, Andersen, L (2003). Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults. Gut 52: 186-193 [Abstract] [Full Text]  
  • Akre, K., Signorello, L. B., Engstrand, L., Bergström, R., Larsson, S., Eriksson, B. I., Nyrén, O. (2000). Risk for Gastric Cancer after Antibiotic Prophylaxis in Patients Undergoing Hip Replacement. Cancer Res. 60: 6376-6380 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest infectious diseases and epidemilogy jobs

Infectious diseases and epidemilogy jobs